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ABSTRACT 
Background and Objectives: Resistance among bacterial isolates is the leading cause of increased mortality and morbidity 
worldwide. Carbapenems once thought to be effective are becoming ineffective mostly due to the emergence of carbapenemase. 
This study was designed to determine in vitro efficacy of Modified Hodge test for detection of carbapenemase production in 
Gram negative rods. 
Material and Methods: The study was done in the Department of Microbiology, Armed Forces Institute of Pathology 
Rawalpindi Pakistan from January 2010 to December 2010. A total of 200 Gram negative rods from different clinical samples 
were taken. Those isolates which showed intermediate or susceptible zones i.e 16mm-21mm on disc diffusion were included 
in the study. These isolates were then subjected to Modified Hodge test.
Result: Out of 200 isolates, 138 (69%) were positive for carbapenemase production by Modified Hodge test. Out of 138 MHT 
positive organisms, the frequency of E. coli was 38%, followed by Pseudomonas aeruginosa (30%), Klebsiella pneumoniae 
(17%), Acinetobacter baumannii (12%), Citrobacter diversus (2%) and Enterobacter agglomerans  (1.4%).
Conclusion: Modified Hodge test is a simple test which can be performed in the routine lab for detection of carbapenemases 
in isolates showing intermediate or sensitive zone diameter on disc diffusion.
Keywords: Modified Hodge test, disc diffusion, carbapenemases
INTRODUCTION
Infections  with  resistant  bacterial  isolates  are 
emerging as an important challenge in health care 
facilities. Antimicrobial resistance is associated with 
adverse  outcomes,  including  increased  mortality, 
hospital  stay  and  costs.  In  addition,  a  delay  in 
institution  of  effective  therapy,  inferior  definitive 
therapy and greater virulence of some resistant strains 
are responsible for antimicrobial resistance (1, 2).
After  methicillin  resistant  staphylococcus  and 
extended  spectrum  beta  lactamases,  another  beta 
lactamase causing resistance among Gram negative 
organisms  is  carbapenemase  enzyme.  This  is  an 
enzyme that hydrolyses a group of antibiotics called 
carbapenems (3, 4). Carbapenems are famously stable 
to  AmpC  β-lactamases  and  extended-spectrum-β-
lactamases (5). This group is considered treatment 
of choice for infections caused by resistant strains 
of Gram negative bacteria. Unfortunately, resistance 
to  carbapenems  in  enterobacteriacae  is  difficult  to 
detect by routine disc diffusion method used by many 
microbiology laboratories.  
Carbapenemases  were  formerly  believed  to  be 
derived only from classes A, B, and D, but a class 
C carbapenemase (CMY) has been described. These 
enzymes fall into three of the Ambler classes of beta- 
lactamases A, B and D (6).
Detection of carbapenemases is difficult. It can be 
detected by phenotypic as well as genotypic methods 
(7). Among  phenotypic  tests,  MHT  is  a  relatively 
easy and simple test to be performed in a laboratory. 
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The study is being undertaken with a view to generally 
screen  the  Gram  negative  rods  for  the  production 
of  carbapenemase  as  these  enzymes  do  not  always 
produce  resistant  breakpoints  for  carbapenems  using 
standardized susceptibility testing methods. The isolate 
may thus be reported as sensitive while still harboring 
carbapenemase enzyme resulting in potential treatment 
failure and dissemination of the resistant isolates.
MATERIAL  AND METHODS
This  study  was conducted in the Department of 
Microbiology, Armed Forces Institute of Pathology 
Rawalpindi Pakistan, from January 2010 to December 
2010. A total of 200 Gram negative rods recovered 
from  different  clinical  samples  including  pus,  pus 
swabs,  urine,  tissue  cultures  and  bronchoalveolar 
lavage were taken. The samples were cultured and 
the  organisms  isolated  were  identified  by  standard 
microbiological  techniques.  The  antimicrobial 
susceptibility  to  carbapenems  was  done  by  disc 
diffusion  method.  Zone  sizes  were  measured 
according  to  CLSI  recommendations.  The  isolates 
which  showed  intermediate  or  susceptible  zones 
for  imipenem,  i.e  16mm-21mm,  were  tested  for 
carbapenemase production by Modified Hodge test, as 
CLSI recommends the MHT to be performed before 
reporting carbapenem susceptibility results if a clinical 
isolates  has  an  elevated  but  susceptible  carbapenem 
MIC (8).
A 0.5 McFarland dilution of the Escherichia coli 
ATCC 25922 in 5 ml of broth or saline was prepared. 
A 1:10 dilution was streaked as lawn on to a Mueller 
Hinton agar plate. A 10 μg meropenem or ertapenem 
susceptibility disk was placed in the center of the test 
area. Test organism was streaked in a straight line 
from the edge of the disk to the edge of the plate. The 
plate was incubated overnight at 35 ± 2oC in ambient 
air for 16-24 hours.  
Quality  control  of  the  carbapenem  disks  were 
performed  according  to  CLSI  guidelines.  Quality 
control  of  the  following  organisms  MHT  Positive 
Klebsiella  pneumoniae  ATCC1705  and  MHT 
Negative  Klebsiella  pneumoniae  ATCC1706  were 
run with each batch of the test.  
After 24 hrs, MHT Positive test showed a clover 
leaf-like indentation of the Escherichia coli 25922 
growing along the test organism growth streak within 
the disk diffusion zone. MHT Negative test showed 
no growth of the Escherichia coli 25922 along the 
test organism growth streak within the disk diffusion 
as shown in Fig. 1.
 Sr. no.     Name of organism Number of  isolates
1  Escherichia coli 52 (38%)
2 Pseudomonas aeruginosa                      42 (30%)
3 Klebsiella pneumoniae 23 (17%)
4 Acinetobacter baumannii                       17 (12%)
5 Citrobacter diversus 3 (2%)
6 Enterobacter agglomerans   2 (1.4%)
Table 1. Bacteria showing positive results in Modified Hodge test (n = 138).
Fig. 1. The MHT performed on a Muller Hinton Agar plate. (1) MHTpositive result (2) MHT negative result; and (3) a 
clinical isolate, positive result.
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RESULTS
Out of a total 200 isolates which were showing 
intermediate or susceptible zone i.e16mm-21mm for 
imipenem, 138(69%) were positive for carbapenemase 
production by Modified Hodge test.
Carbapenemase  producing  organisms  were 
E.coli 38%, followed by Pseudomonas aeruginosa 
30%,  Klebsiella  pneumoniae  17%,  Acinetobacter 
baumannii 12%, and Citrobacter diversus 2% and 
Enterobacter agglomerans were 1.4% (Table 1).
DISCUSSION
For  more  than  2  decades  carbapenems  have 
been  considered  the  treatment  of  last  resort  for 
managing  multidrug  resistant  infections  caused 
by  Enterobacteriacae.  Carbapenemases,  which 
hydrolyzes carbapenems and renders them inactive, 
have been increasingly reported in Asia and Europe, 
and more recently have been detected in Canada and 
the United States (10-14). 
In 1996, the first isolate of Klebsiella pneumoniae 
Carbapenemase  (KPC)  producing  organism  was 
isolated in a clinical specimen from a hospital in North 
Carolina involved in the Intensive Care Antimicrobial 
Resistance  Epidemiology  (ICARE)  surveillance 
program.  KPCs  were  infrequently  isolated  until 
2001, when KPC-producing Enterobacteriaceae were 
reported in several extended outbreaks in different 
hospitals of New York and New Jersey (15-17). KPCs 
have also been found in K. oxytoca (18), Escherichia 
coli  (19),  Citrobacter  spp  (20),  Pseudomonas 
aeruginosa  (21),  Salmonella  spp  (22),  Serratia 
marcescens (20), as well as Proteus mirabilis (23).
The Modified Hodge test as it is described today is a 
modified version of Hodge test which was used some 
years ago. Even the original Hodge test was evaluated 
utilizing  the  PCR  confirmed  IMP-1  and  VIM-2 
Metallo β-lactamase (MBL) producing isolates. The 
original  Hodge  test  utilized  imipenem  10µg  disc 
which  gave  fairly good  results  as  it  detected 67% 
cases of MBL producing Pseudomonas aeruginosa 
and  Acinetobacter  spp.  The  other  13  cases  which 
gave  initially  equivocal  or  negative  results  were 
retested and were declared positive using imipenem 
discs containing zinc sulphate (24).
In  another  study  done  at  Centers  for  Disease 
Control and Prevention in Atlanta GA in 2007, 45 
isolates (26 of K. pneumoniae, 9 of K. oxytoca, and 
10  of  E.  coli)  were  evaluated  by  Modified  Hodge 
test and all of them were validated by PCR for the 
detection of KPC activity with 100% sensitivity and 
specificity (25). This shows that Modified Hodge test 
is a very sensitive and reliable test for detection of 
carbapenemases.
A  study  was  carried  out  in  Greece  in  2007  to 
evaluate  different  laboratory  tests  for  detection  of 
MBLs  in  Enterobacteriacae.  Modified  Hodge  test 
detected 98% cases keeping PCR as the gold standard 
while only 0.03% was detected as false positive (26).
Recently  a  study  done  in  Pennsylvania  revealed 
that  out  of  85  ertapenem  intermediate  or  resistant 
isolates,  75%  were  KPC  (Klebsiella  pneumoniae 
carbapenemase) positive tested by Modified Hodge 
test and further confirmed by PCR (27). While in our 
study  out  of  100  isolates  which  were  carbapenem 
intermediate or sensitive, 69% showed the presence 
of carbapenemase by Modified Hodge test only.
Recently a latest version of carbapenemases, New 
Delhi  metallo-β-  lactamase-1(NDM-1)  is  making 
headlines all over the world (28). Though the definite 
diagnosis  of  NDM-1  rests  on  PCR  but  Modified 
Hodge test can be a very useful screening test for 
suspecting such cases for epidemiological purpose.
In  many  healthcare  facilities  around  the  world, 
bacterial pathogens that express multiple resistance 
mechanisms  are  becoming  rampant,  complicating 
treatment  and  increasing  both  human  morbidity 
and  financial  costs.  This  necessitates  the  need  for 
detecting the resistant bacteria so that unnecessary 
use of broad spectrum antimicrobials can be avoided. 
The significant finding of our study was the fact that 
quite a large percentage i.e 69% of our isolates which 
showed intermediate or susceptible zone sizes on disc 
diffusion were detected positive by MHT indicating 
the huge importance of this simple test. Hence majority 
of such patients would be prescribed carbapenems 
which would be disastrous on two accounts, firstly 
the  patient  would  end  up  in  treatment  failure  and 
secondly unnecessary usage of carbapenems would 
further expose this antimicrobial with potential for 
more resistance.
In conclusion, Modified Hodge test is an easy and 
simple test to be performed to detect carbapenemases 
producing bacteria .There is a very high percentage 
of carbapenemases producing Gram negative rods in 
our setup. It is imperative that all isolates showing 
intermediate  or  sensitive  zone  diameter  on  disc 
diffusion be tested for production of carbapenemases 192 AMjAD  ET AL .                                                                                                 IRAN. J. MICROBIOL. 3 (4) : 189-193 
by Modified Hodge test to avoid treatment failures 
and development of resistance due to unnecessary use 
of this class of antibiotic.
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